136 results on '"Christoffersen, Christina"'
Search Results
2. Dual-release hydrocortisone improves body composition and the glucometabolic profile in patients with secondary adrenal insufficiency
3. Myocardial work in chronic kidney disease: insights from the CPH-CKD ECHO Study
4. Blood biomarkers improve the prediction of prevalent and incident severe chronic kidney disease
5. The adipocyte apolipoprotein M is negatively associated with inflammation
6. Identification of Glomerular and Plasma Apolipoprotein M as Novel Biomarkers in Glomerular Disease
7. Apolipoprotein M Attenuates Anthracycline Cardiotoxicity and Lysosomal Injury
8. Left ventricular structure and function in patients with chronic kidney disease assessed by 3D echocardiography: the CPH-CKD ECHO study
9. Associations Between Albuminuria, Estimated GFR and Cardiac Phenotype in a Cohort with Chronic Kidney Disease: The CPH-CKD ECHO Study
10. Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes
11. The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease
12. Association of apolipoprotein M and sphingosine-1-phosphate with brown adipose tissue after cold exposure in humans
13. Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice
14. Apolipoprotein M and its impact on endothelial dysfunction and inflammation in the cardiovascular system
15. Galnt11 regulates kidney function by glycosylating the endocytosis receptor megalin to modulate ligand binding
16. Strain Engineering: Perfecting Freestanding Perovskite Oxide Fabrication.
17. Transition Metal‐Oxide Nanomembranes Assembly by Direct Heteroepitaxial Growth.
18. The cellular composition of chronic subdural hematoma.
19. Oral pre-treatment with thiocyanate (SCN−) protects against myocardial ischaemia–reperfusion injury in rats
20. Discovery of plasma proteins associated with ventricular fibrillation during first ST-elevation myocardial infarction via proteomics.
21. Apolipoprotein M in patients with chronic kidney disease
22. Regional distribution and severity of arterial calcification in patients with chronic kidney disease stages 1–5: a cross-sectional study of the Copenhagen chronic kidney disease cohort
23. Apolipoprotein E Deficiency Increases Remnant Lipoproteins and Accelerates Progressive Atherosclerosis, But Not Xanthoma Formation, in Gene-Modified Minipigs
24. Effects of apolipoprotein M in uremic atherosclerosis
25. High density lipoprotein (HDL)-associated sphingosine 1-phosphate (S1P) inhibits macrophage apoptosis by stimulating STAT3 activity and survivin expression
26. Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
27. Kidney derived apolipoprotein M and its role in acute kidney injury.
28. Plasma activin A rises with declining kidney function and is independently associated with mortality in patients with chronic kidney disease.
29. Loss of Function of GALNT2 Lowers High-Density Lipoproteins in Humans, Nonhuman Primates, and Rodents
30. Super-Resolution Ultrasound Imaging of Renal Vascular Alterations in Zucker Diabetic Fatty Rats during the Development of Diabetic Kidney Disease.
31. ApoB and apoM – New aspects of lipoprotein biology in uremia-induced atherosclerosis
32. Coronary and extra-coronary artery calcium scores as predictors of cardiovascular events and mortality in chronic kidney disease stages 1–5: a prospective cohort study.
33. Diabetes with poor glycaemic control does not promote atherosclerosis in genetically modified hypercholesterolaemic minipigs
34. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M
35. Sphingosine-1-phosphate reduces ischaemia–reperfusion injury by phosphorylating the gap junction protein Connexin43
36. Gestational Hypertension and High-Density Lipoprotein Function: An Explorative Study in Overweight/Obese Women of the DALI Cohort.
37. Apolipoprotein M in lipid metabolism and cardiometabolic diseases
38. ApoM: gene regulation and effects on HDL metabolism
39. Super-Resolution Ultrasound Imaging Provides Quantification of the Renal Cortical and Medullary Vasculature in Obese Zucker Rats: A Pilot Study.
40. Arg82Cys Polymorphism of the Protein Nepmucin Implies a Role in HDL Metabolism.
41. Apolipoprotein M: bridging HDL and endothelial function
42. Osteopontin deficiency dampens the pro-atherogenic effect of uraemia
43. Iodide as a potential therapeutic in atherosclerosis.
44. Endothelial-Specific Loss of Sphingosine-1-Phosphate Receptor 1 Increases Vascular Permeability and Exacerbates Bleomycin-induced Pulmonary Fibrosis.
45. Carotid plaque thickness is increased in chronic kidney disease and associated with carotid and coronary calcification.
46. Apolipoprotein M: structure and function
47. Diabetes and the endocrine heart
48. Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein.
49. Apolipoprotein M—A Marker or an Active Player in Type II Diabetes?
50. Apolipoprotein M and Risk of Type 2 Diabetes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.